Transcriptome-informed multi-modal AI for predicting neoadjuvant therapy response from breast cancer biopsies
A two-stage AI model predicting pathological complete response to neoadjuvant therapy in breast cancer and transcriptome-wide inference improves discrimination over clinical variables alone or one-stage pathology models, and robustness by avoiding genomic assays'gene selection constraints are developed.